DSS, INC.
SEC Form 4 insider trading activity
DSS, INC. has filed 2 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Sep 24, 2026.
On the most recent filing, DSS, INC. is listed as 10% Owner at IMPACT BIOMEDICAL INC. Inside the rolling window, DSS, INC. reported no open-market purchases and 5 open-market sales totaling $90K in IBO. The largest disclosed transaction in the window is a sale of 115,600 IBO shares on May 22, 2025, worth $63K.
Companies traded
Other insiders at IBO
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$90K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has DSS, INC. made?
DSS, INC. has filed 2 SEC Form 4 filings (5 transaction rows) across 1 company since 2026.
Which companies does DSS, INC. trade?
DSS, INC. has filed SEC Form 4 disclosures for 1 company, including IBO.
When was DSS, INC.'s most recent SEC Form 4 filing?
DSS, INC.'s most recent SEC Form 4 filing on Tracefour is dated Sep 24, 2026.
What is DSS, INC.'s total buy and sell value in the current window?
Inside the rolling retention window, DSS, INC. bought $0 and sold $90K based on SEC Form 4 filings.
What was DSS, INC.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 115,600 IBO shares on 2025-05-22, worth $63K, per SEC Form 4 filings.